Un brote de angioedema hereditario inducido por el COVID-19 en una paciente de 12 años
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.COVID-19 puede desencadenar brotes de angioedema hereditario (HAE) en niños al aumentar los niveles de bradicinina, similar a la fisiopatología de la HAE. Este informe de caso destaca la importancia de reconocer el COVID-19 como un posible desencadenante de EHA en pacientes pediátricos.
Área De La Ciencia
- Inmunología
- Virología
- Pediatría
Sus Antecedentes
- El angioedema hereditario (EAH) es un trastorno genético raro que causa inflamación recurrente debido a la acumulación de bradicinina.
- La infección por SARS-CoV-2 deteriora la degradación de la bradicinina a través de ACE2, imitando la fisiopatología de la AEH.
- El COVID-19 se ha relacionado con exacerbaciones de HAE en adultos, pero los casos pediátricos son raros.
Objetivo Del Estudio
- Para informar el primer caso detallado de un paciente pediátrico con EHA que experimenta un brote provocado por COVID-19.
- Aumentar la concienciación sobre el COVID-19 como un posible desencadenante de HAE en los niños.
- Hacer hincapié en la necesidad de educación pediátrica para el manejo de brotes de EAE durante la pandemia.
Principales Métodos
- Informe de caso de un paciente pediátrico con diagnóstico de AEH.
- Documentación de la progresión de los síntomas y la línea de tiempo del tratamiento después de la infección por SARS-CoV-2.
- Revisión de la vía fisiopatológica compartida que involucra a la bradicinina y la ACE2.
Principales Resultados
- El paciente pediátrico con HAE experimentó un brote de enfermedad después de contraer COVID-19.
- El mecanismo del brote involucró la desregulación de la bradicinina inducida por el SARS-CoV-2, consistente con la AEH.
- Este caso proporciona una línea de tiempo detallada de aparición de síntomas y manejo en un paciente pediátrico con EHA con COVID-19.
Conclusiones
- El COVID-19 puede servir como un desencadenante significativo para los brotes de HAE en las poblaciones pediátricas.
- Los proveedores de atención médica deben educar a las familias de pacientes pediátricos con EAH sobre la preparación para brotes relacionados con el COVID-19.
- La vigilancia y la concienciación continuas son cruciales dada la circulación mundial en curso del SARS-CoV-2.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Overview
We speak of an allergy when the immune system triggers a response against a benign foreign structure, like food, pollen or pet dander. These elicitors are called allergens. If the immune system of a hypersensitive individual was primed against a specific allergen, it will trigger allergic symptoms during every subsequent encounter of the allergen. Symptoms can be mild, such as hay fever, to severe, such as potentially fatal anaphylactic shock.
Sensitization Is the First Step of an...
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Detailed Medical History: This includes asking about symptoms such as wheezing, coughing, chest tightness, and breathlessness. Information about triggers like exercise, allergens, or cold air is crucial.
Physical...